New Hope, PA, United States of America

Robert Michael Borzilleri

USPTO Granted Patents = 60 

 

 

Average Co-Inventor Count = 4.4

ph-index = 13

Forward Citations = 529(Granted Patents)

Forward Citations (Not Self Cited) = 471(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • New Hope, NJ (US) (2012)
  • Lawrenceville, NJ (US) (2002 - 2013)
  • Princeton, NJ (US) (2017)
  • New Hope, PA (US) (2001 - 2018)
  • Carversville, PA (US) (2016 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
60 patents (USPTO):

Title: Unveiling the Innovative Work of Inventor Robert Michael Borzilleri

Introduction:

Robert Michael Borzilleri, a visionary inventor based in New Hope, PA (US), has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 59 patents. His groundbreaking research has led to the development of novel compounds and pharmaceutical compositions that have the potential to revolutionize the treatment of various diseases.

Latest Patents:

Among his latest patents is the development of TGF-beta inhibitors, encompassing imidazole and thiazole compounds that demonstrate promising pharmacological activities. These compounds hold immense potential in inhibiting TGF-β signaling, thereby offering new therapeutic avenues for diseases associated with dysregulated TGF-β pathways. Additionally, Borzilleri's work on TGF beta receptor antagonists, which modulate the activity of TGFβR-1 and TGFβR-2, shows great promise in treating proliferative disorders, including cancer.

Career Highlights:

Throughout his illustrious career, Borzilleri has made significant contributions to renowned companies in the pharmaceutical industry. He has lent his expertise to esteemed organizations such as Bristol-Myers Squibb Company and Rigel Pharmaceuticals, Incorporated, where he has played a pivotal role in driving innovation and advancing drug discovery efforts.

Collaborations:

In his collaborative endeavors, Borzilleri has worked closely with accomplished individuals in the field of pharmaceutical research. Notable colleagues include Zhen-Wei Cai and Gregory D. Vite, whose collective efforts have led to the successful development of groundbreaking pharmaceutical compounds under Borzilleri's guidance.

Conclusion:

Inventor Robert Michael Borzilleri's relentless pursuit of innovation and excellence in the pharmaceutical industry has resulted in a prolific patent portfolio that stands as a testament to his ingenuity. His groundbreaking work in developing novel compounds and pharmaceutical compositions holds immense promise for transforming the landscape of therapeutic interventions, offering hope for improved treatment outcomes in various disease conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…